Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C (2009). “Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure”. Steroids. 74 (2): 172–97. doi:10.1016/j.steroids.2008.10.016. PMID19028512.
Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, Coles SJ, Walker CJ (2015). “Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health”. Drug Test Anal. 7 (7): 609–18. doi:10.1002/dta.1728. PMID25284752.
nih.gov
pubmed.ncbi.nlm.nih.gov
Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C (2009). “Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure”. Steroids. 74 (2): 172–97. doi:10.1016/j.steroids.2008.10.016. PMID19028512.
Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, Coles SJ, Walker CJ (2015). “Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health”. Drug Test Anal. 7 (7): 609–18. doi:10.1002/dta.1728. PMID25284752.